{"DataElement":{"publicId":"6260060","version":"1","preferredName":"Erythema Multiforme Minor And/Or Toxic Epidermal Necrolysis Disease or Disorder Occurrence Type","preferredDefinition":"A description of the erythema multiforme minor and/or toxic epidermal necrolysis disease or disorder.","longName":"6260054v1.0:6260057v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6260054","version":"1","preferredName":"Erythema Multiforme Minor And/Or Toxic Epidermal Necrolysis Disease or Disorder Occurrence","preferredDefinition":"Self-limiting form of erythema multiforme._Used to indicate that either or both of two items or options may be valid._A systemic, serious, and life-threatening disorder characterized by erythematous and necrotic lesions in the skin and mucous membranes that are associated with bullous detachment of the epidermis. The epidermal and mucous membranes detachment leads to sepsis and may be fatal. The lesions appear throughout the body and occupy more than 30% of the body surfaces. It is a hypersensitivity reaction usually caused by drugs (e.g., sulfonamides, nonsteroidal anti-inflammatory drugs, anticonvulsants, and antiretroviral drugs)._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._An instance of something happening, such as an event or incident.","longName":"6260052v1.0:2234856v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6260052","version":"1","preferredName":"Erythema Multiforme Minor And/Or Toxic Epidermal Necrolysis Disease or Disorder","preferredDefinition":"Self-limiting form of erythema multiforme.:Used to indicate that either or both of two items or options may be valid.:A systemic, serious, and life-threatening disorder characterized by erythematous and necrotic lesions in the skin and mucous membranes that are associated with bullous detachment of the epidermis. The epidermal and mucous membranes detachment leads to sepsis and may be fatal. The lesions appear throughout the body and occupy more than 30% of the body surfaces. It is a hypersensitivity reaction usually caused by drugs (e.g., sulfonamides, nonsteroidal anti-inflammatory drugs, anticonvulsants, and antiretroviral drugs).:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C8924:C48928:C79777:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erythema Multiforme Minor","conceptCode":"C8924","definition":"Self-limiting form of erythema multiforme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Toxic Epidermal Necrolysis","conceptCode":"C79777","definition":"A systemic, serious, and life-threatening disorder characterized by erythematous and necrotic lesions in the skin and mucous membranes that are associated with bullous detachment of the epidermis. The epidermal and mucous membranes detachment leads to sepsis and may be fatal. The lesions appear throughout the body and occupy more than 30% of the body surfaces. It is a hypersensitivity reaction usually caused by drugs (e.g., sulfonamides, nonsteroidal anti-inflammatory drugs, anticonvulsants, and antiretroviral drugs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3966A4-9696-27D8-E053-F662850A276B","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"ONEDATA","dateModified":"2018-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3966A4-96A4-27D8-E053-F662850A276B","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"KUMMEROA","dateModified":"2018-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6260057","version":"1","preferredName":"Erythema Multiforme Minor And/Or Toxic Epidermal Necrolysis Type","preferredDefinition":"Self-limiting form of erythema multiforme._Used to indicate that either or both of two items or options may be valid._A systemic, serious, and life-threatening disorder characterized by erythematous and necrotic lesions in the skin and mucous membranes that are associated with bullous detachment of the epidermis. The epidermal and mucous membranes detachment leads to sepsis and may be fatal. The lesions appear throughout the body and occupy more than 30% of the body surfaces. It is a hypersensitivity reaction usually caused by drugs (e.g., sulfonamides, nonsteroidal anti-inflammatory drugs, anticonvulsants, and antiretroviral drugs)._Something distinguishable as an identifiable class based on common qualities.","longName":"6260057v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Photosensitivity","valueDescription":"Photosensitivity","ValueMeaning":{"publicId":"2946036","version":"1","preferredName":"Photosensitivity","longName":"2946036","preferredDefinition":"Increased sensitivity of the skin to light.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Photosensitivity","conceptCode":"C38004","definition":"Increased sensitivity of the skin to light exposure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D468-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6B3BE51F-8BE1-5E97-E053-F662850AC4B9","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"ONEDATA","dateModified":"2018-05-02","deletedIndicator":"No"},{"value":"Flushing","valueDescription":"Flushing","ValueMeaning":{"publicId":"2944829","version":"1","preferredName":"Flushing","longName":"2944829","preferredDefinition":"A sudden reddening of the face.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Flushing","conceptCode":"C26775","definition":"Reddening of the skin from a transient increase in blood flow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74450F48-3417-F0DB-E040-BB89AD437C48","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6B3BE51F-8BEB-5E97-E053-F662850AC4B9","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"ONEDATA","dateModified":"2018-05-02","deletedIndicator":"No"},{"value":"Erythematous rash","valueDescription":"Erythema Multiforme Minor","ValueMeaning":{"publicId":"6260059","version":"1","preferredName":"Erythema Multiforme Minor","longName":"6260059","preferredDefinition":"Self-limiting form of erythema multiforme.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erythema Multiforme Minor","conceptCode":"C8924","definition":"Self-limiting form of erythema multiforme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3BE51F-8BF7-5E97-E053-F662850AC4B9","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"ONEDATA","dateModified":"2018-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6B3BE51F-8C10-5E97-E053-F662850AC4B9","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"ONEDATA","dateModified":"2018-05-02","deletedIndicator":"No"},{"value":"Stevens-Johnson syndrome / Toxic epidermal necrolysis","valueDescription":"Stevens-Johnson Syndrome And/Or Toxic Epidermal Necrolysis Disease or Disorder","ValueMeaning":{"publicId":"6260058","version":"1","preferredName":"Stevens-Johnson Syndrome And/Or Toxic Epidermal Necrolysis Disease or Disorder","longName":"6260058","preferredDefinition":"A systemic, serious, and life-threatening disorder characterized by lesions in the skin and mucous membranes that may lead to necrosis. The lesions may appear anywhere in the body but they occur more commonly in the palms, soles, dorsum of the hands, and extensor surfaces. The lesions are vesicular or necrotic in the center, surrounded by an erythematous zone and occupy less than 10% of the body surfaces. The appearance of the mucocutaneous lesions is preceded by an upper respiratory tract infection. It is an immune complex hypersensitivity reaction usually caused by drugs (e.g., sulfa, phenytoin, penicillin), viruses (e.g., herpes simplex, influenza, hepatitis), and malignancies (e.g., carcinoma and lymphoma).: Used to indicate that either or both of two items or options may be valid.: A systemic, serious, and life-threatening disorder characterized by erythematous and necrotic lesions in the skin and mucous membranes that are associated with bullous detachment of the epidermis. The epidermal and mucous membranes detachment leads to sepsis and may be fatal. The lesions appear throughout the body and occupy more than 30% of the body surfaces. It is a hypersensitivity reaction usually caused by drugs (e.g., sulfonamides, nonsteroidal anti-inflammatory drugs, anticonvulsants, and antiretroviral drugs).: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stevens-Johnson Syndrome","conceptCode":"C79484","definition":"A systemic, serious, and life-threatening disorder characterized by lesions in the skin and mucous membranes that may lead to necrosis. The lesions may appear anywhere in the body but they occur more commonly in the palms, soles, dorsum of the hands, and extensor surfaces. The lesions are vesicular or necrotic in the center, surrounded by an erythematous zone and occupy less than 10% of the body surfaces. The appearance of the mucocutaneous lesions is preceded by an upper respiratory tract infection. It is an immune complex hypersensitivity reaction usually caused by drugs (e.g., sulfa, phenytoin, penicillin), viruses (e.g., herpes simplex, influenza, hepatitis), and malignancies (e.g., carcinoma and lymphoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Toxic Epidermal Necrolysis","conceptCode":"C79777","definition":"A systemic, serious, and life-threatening disorder characterized by erythematous and necrotic lesions in the skin and mucous membranes that are associated with bullous detachment of the epidermis. The epidermal and mucous membranes detachment leads to sepsis and may be fatal. The lesions appear throughout the body and occupy more than 30% of the body surfaces. It is a hypersensitivity reaction usually caused by drugs (e.g., sulfonamides, nonsteroidal anti-inflammatory drugs, anticonvulsants, and antiretroviral drugs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3BE51F-8BBE-5E97-E053-F662850AC4B9","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"ONEDATA","dateModified":"2018-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"700A3E84-A978-431B-E053-F662850AF27C","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-07-03","modifiedBy":"ONEDATA","dateModified":"2018-07-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6260056","version":"1","preferredName":"Erythema Multiforme Minor And/Or Toxic Epidermal Necrolysis Type","preferredDefinition":"Self-limiting form of erythema multiforme.:Used to indicate that either or both of two items or options may be valid.:A systemic, serious, and life-threatening disorder characterized by erythematous and necrotic lesions in the skin and mucous membranes that are associated with bullous detachment of the epidermis. The epidermal and mucous membranes detachment leads to sepsis and may be fatal. The lesions appear throughout the body and occupy more than 30% of the body surfaces. It is a hypersensitivity reaction usually caused by drugs (e.g., sulfonamides, nonsteroidal anti-inflammatory drugs, anticonvulsants, and antiretroviral drugs).:Something distinguishable as an identifiable class based on common qualities.","longName":"C8924:C48928:C79777:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Erythema Multiforme Minor","conceptCode":"C8924","definition":"Self-limiting form of erythema multiforme.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Toxic Epidermal Necrolysis","conceptCode":"C79777","definition":"A systemic, serious, and life-threatening disorder characterized by erythematous and necrotic lesions in the skin and mucous membranes that are associated with bullous detachment of the epidermis. The epidermal and mucous membranes detachment leads to sepsis and may be fatal. The lesions appear throughout the body and occupy more than 30% of the body surfaces. It is a hypersensitivity reaction usually caused by drugs (e.g., sulfonamides, nonsteroidal anti-inflammatory drugs, anticonvulsants, and antiretroviral drugs).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3BE51F-8B92-5E97-E053-F662850AC4B9","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"ONEDATA","dateModified":"2018-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3BE51F-8BA3-5E97-E053-F662850AC4B9","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"KUMMEROA","dateModified":"2018-07-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the erythema multifo","type":"Preferred Question Text","description":"What was the erythema multiforme minor and/or toxic epidermal necrolysis disease or disorder?","url":null,"context":"NHLBI"},{"name":"Symptoms","type":"Alternate Question Text","description":"Symptoms","url":null,"context":"NHLBI"},{"name":"Symptoms","type":"Application Standard Question Text","description":"Symptoms","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B3B11BE-1E85-2555-E053-F662850A6778","latestVersionIndicator":"Yes","beginDate":"2018-05-02","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-05-02","modifiedBy":"KUMMEROA","dateModified":"2018-07-25","changeDescription":".; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}